Please assess the completion status of the following clinical trial:

Trial Title: Immunomodulation by Zinc Supplementation in Children With Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children 1 month to 5 years old with clinical and/or radiological diagnosis of pneumonia~* Admitted to the Emergency room at the participant institutions~Exclusion Criteria:~* Prematurity~* Cardiopathy~* Pneumopathy~* Immunosuppression (congenital, chemotherapy or other cause)

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Zinc group (Type: EXPERIMENTAL): Zinc sulfate 10 mg in children younger than 1 year old, 20 mg in children older than 1 year old
- Placebo group (Type: PLACEBO_COMPARATOR): Glucose

Based on this trial design, predict the completion outcome and termination type (if applicable).